TL1 inhibitors (Sequella)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTL1 inhibitors (Sequella)
Drug Alias Nametranslocase 1 inhibitors (Sequella)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPhospho-N-acetylmuramoyl pentapeptide transferase inhibitors
TargetsPhospho-N-acetylmuramoyl pentapeptide transferase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSequella Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSequella Inc
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A